Cargando…
Modelling acute myeloid leukemia (AML): What’s new? A transition from the classical to the modern
Acute myeloid leukemia (AML) is a heterogeneous malignancy affecting myeloid cells in the bone marrow (BM) but can spread giving rise to impaired hematopoiesis. AML incidence increases with age and is associated with poor prognostic outcomes. There has been a disconnect between the success of novel...
Autores principales: | Dozzo, Annachiara, Galvin, Aoife, Shin, Jae-Won, Scalia, Santo, O’Driscoll, Caitriona M., Ryan, Katie B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315355/ https://www.ncbi.nlm.nih.gov/pubmed/35930221 http://dx.doi.org/10.1007/s13346-022-01189-4 |
Ejemplares similares
-
Nano-Hydroxyapatite/PLGA Mixed Scaffolds as a Tool for Drug Development and to Study Metastatic Prostate Cancer in the Bone
por: Dozzo, Annachiara, et al.
Publicado: (2023) -
The Question of Survival or Death: What Is the Role of Autophagy in Acute Myeloid Leukemia (AML)?
por: Haghi, Atousa, et al.
Publicado: (2022) -
Strategies to Mitigate and Treat Orthopaedic Device-Associated Infections
por: Kennedy, Darragh G., et al.
Publicado: (2022) -
Chromosomal rearrangements in acute myeloid leukemia (AML)
por: Belloni, E, et al.
Publicado: (2010) -
New agents in acute myeloid leukemia (AML)
por: Park, Silvia, et al.
Publicado: (2020)